Clinical Trial

Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is a non-randomized, multi-center, open-label, prospective clinical trial evaluating clinical treatments with the Matrix Pro Applicator for the improvement of facial and/or submental and neck laxity.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-05; most recent amendment 2025-06-12.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-06-12
Trial Details
NCT Number NCT06726122
Lead Sponsor Candela Corporation
Conditions Skin Laxity, Wrinkle, Skin Condition
Enrollment 60 participants
Start Date 2025-01-28
Primary Completion 2028-01 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-15